Wei Li

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Biomedicines

Science translational medicine

Cellular and molecular life sciences : CMLS

International journal of molecular sciences

University of Miami School of Medicine

University of Nebraska Medical Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Miami School of Medicine May 01 2013

United States

Associate Professor :: Ophthalmology

University of Miami School of Medicine Sep 02 2002 - Apr 30 2013

United States

Assistant Professor :: Ophthalmology

New England Medical Center/Tufts University Jul 01 2001 - Aug 31 2002

United States

Instructor :: Pediatrics

New England Medical Center Jul 01 1996 - Jun 30 2001

United States

Postdoctoral Associate :: Pediatrics

Yale University School of Medicine Dec 01 1991 - Jul 01 1996

United States

Postdoctoral Associate :: Pharmacology

Education History

University of Nebraska Medical Center Sep 01 1986 - Dec 31 1991

United States

PHD :: Pharmacology

Zhejiang University School of Medicine Aug 01 1983 - Jul 01 1986

China

MSC :: Pharmacology

Zhejiang University School of Medicine Aug 01 1979 - Jul 01 1986

China

BSC :: Pharmacy

Publications

Qiuhua Yang, Yongfeng Cai, Qian Ma, Albert Xiong, Peishan Xu, Zhidan Zhang, Jiean Xu, Yaqi Zhou, Zhiping Liu, Dingwei Zhao, John M Asara, Wei Li, Huidong Shi, Ruth B Caldwell, Akrit Sodhi, Yuqing Huo
Inactivation of adenosine receptor 2A suppresses endothelial-to-mesenchymal transition and inhibits subretinal fibrosis in mice. Science translational medicine 16 (737) (2024)
Chengchi Huang, Prabuddha Waduge, Avinash Kaur, Hong Tian, Christina Y Weng, John Timothy Stout, Iok-Hou Pang, Keith A Webster, Wei Li
Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy. International journal of molecular sciences 25 (17) (2024)
Qiuhua Yang, Yongfeng Cai, Qian Ma, Albert Xiong, Peishan Xu, Zhidan Zhang, Jiean Xu, Yaqi Zhou, Zhiping Liu, Dingwei Zhao, John M Asara, Wei Li, Huidong Shi, Ruth B Caldwell, Akrit Sodhi, Yuqing Huo
Inactivation of adenosine receptor 2A suppresses endothelial-to-mesenchymal transition and inhibits subretinal fibrosis in mice. Science translational medicine 16 (737) (2024)
Qiuhua Yang, Yongfeng Cai, Qian Ma, Albert Xiong, Peishan Xu, Zhidan Zhang, Jiean Xu, Yaqi Zhou, Zhiping Liu, Dingwei Zhao, John M Asara, Wei Li, Huidong Shi, Ruth B Caldwell, Akrit Sodhi, Yuqing Huo
Inactivation of adenosine receptor 2A suppresses endothelial-to-mesenchymal transition and inhibits subretinal fibrosis in mice. Science translational medicine 16 (737) (2024)
Qiuhua Yang, Yongfeng Cai, Qian Ma, Albert Xiong, Peishan Xu, Zhidan Zhang, Jiean Xu, Yaqi Zhou, Zhiping Liu, Dingwei Zhao, John M Asara, Wei Li, Huidong Shi, Ruth B Caldwell, Akrit Sodhi, Yuqing Huo
Inactivation of adenosine receptor 2A suppresses endothelial-to-mesenchymal transition and inhibits subretinal fibrosis in mice. Science translational medicine 16 (737) (2024)
Liyang Ji, Prabuddha Waduge, Yan Wu, Chengchi Huang, Avinash Kaur, Paola Oliveira, Hong Tian, Jinsong Zhang, J Timothy Stout, Christina Y Weng, Keith A Webster, Wei Li
Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy. International journal of molecular sciences 24 (13) (2023)
Chengchi Huang, Liyang Ji, Avinash Kaur, Hong Tian, Prabuddha Waduge, Keith A Webster, Wei Li
Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice. Biomedicines 11 (7) (2023)
Benjamin Pomeroy, Alexander W Venanzi, Wei Li, Abigail S Hackam, Midhat H Abdulreda
Fluorescence Angiography with Dual Fluorescence for the Early Detection and Longitudinal Quantitation of Vascular Leakage in Retinopathy. Biomedicines 11 (2) (2023)
Benjamin Pomeroy, Alexander W Venanzi, Wei Li, Abigail S Hackam, Midhat H Abdulreda
Fluorescence Angiography with Dual Fluorescence for the Early Detection and Longitudinal Quantitation of Vascular Leakage in Retinopathy. Biomedicines 11 (2) (2023)
Benjamin Pomeroy, Alexander W Venanzi, Wei Li, Abigail S Hackam, Midhat H Abdulreda
Fluorescence Angiography with Dual Fluorescence for the Early Detection and Longitudinal Quantitation of Vascular Leakage in Retinopathy. Biomedicines 11 (2) (2023)
Chang Dai, Jun Xiao, Chenguang Wang, Wei Li, Guan-Fang Su
Neurovascular abnormalities in retinopathy of prematurity and emerging therapies. Journal of molecular medicine (Berlin, Germany) 100 (6) (2022)
Chang Dai, Prabuddha Waduge, Liyang Ji, Chengchi Huang, Ye He, Hong Tian, Elizabeth Zuniga-Sanchez, Amit Bhatt, Iok-Hou Pang, Guanfang Su, Keith A Webster, Wei Li
Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy. Cellular and molecular life sciences : CMLS 79 (1) (2022)
Liyang Ji, Prabuddha Waduge, Lili Hao, Avinash Kaur, Wencui Wan, Yan Wu, Hong Tian, Jinsong Zhang, Keith A Webster, Wei Li
Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (1) (2022)
Liyang Ji, Prabuddha Waduge, Wencui Wan, Hong Tian, Jin Li, Jinsong Zhang, Rui Chen, Wei Li
Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization. The FEBS journal 289 (12) (2022)
Ye He, Hong Tian, Chang Dai, Rong Wen, Xiao-Rong Li, Keith A Webster, Wei Li
Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy. International journal of molecular sciences 23 (1) (2021)
Liyang Ji, Hong Tian, Keith A Webster, Wei Li
Neurovascular regulation in diabetic retinopathy and emerging therapies. Cellular and molecular life sciences : CMLS 78 (16) (2021)
Fen Tang, Michelle E LeBlanc, Weiwen Wang, Dan Liang, Ping Chen, Tsung-Han Chou, Hong Tian, Wei Li
Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety. Angiogenesis 22 (3) (2019)
Wei Li, Keith A Webster, Michelle E LeBlanc, Hong Tian
Secretogranin III: a diabetic retinopathy-selective angiogenic factor. Cellular and molecular life sciences : CMLS 75 (4) (2017)
Michelle E LeBlanc, Weiwen Wang, Xiuping Chen, Nora B Caberoy, Feiye Guo, Chen Shen, Yanli Ji, Hong Tian, Hui Wang, Rui Chen, Wei Li
Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy. The Journal of experimental medicine 214 (4) (2017)
Weiwen Wang, Michelle E LeBlanc, Xiuping Chen, Ping Chen, Yanli Ji, Megan Brewer, Hong Tian, Samantha R Spring, Keith A Webster, Wei Li
Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease. Angiogenesis 20 (4) (2017)

Wei Li.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wei Li